曹忠莲

1. Zhonglian Cao, Meredith Wright, Jiekai Cheng, Xiaoxing Huang, Li Liu, Lixing Wu, Ping Yang. The novel bis-benzylisoquinoline PY35 reverses P-glycoprotein-mediated multidrug resistance. Oncology Reports, 2014, 32:1211-1217
2. Kairong Shi, Jianping Li, Zhonglian Cao, Ping Yang, Yue Qiu, Bo Yang, YangWang, Yang Long,Yayuan Liu, Qianyu Zhang, Jun Qian, Zhirong Zhang, Huile Gao, Qin He. A pH-responsive cell-penetrating peptide-modified liposomes with active recognizing of integrin αvβ3 for the treatment of melanoma. Journal of Controlled Release, 2015, 217: 138-150
3. Ping Song, Li Ye, Jiajun Fan, Yubin Li, Xian Zeng, Ziyu Wang, Shaofei Wang, Guoping Zhang, Ping Yang, Zhonglian Cao, Dianwen Ju. Asparaginase induces apoptosis and cytoprotective autophagy in chronic myeloid leukemia cells. Oncotarget, 2014, 6 (6): 3861-3873
4. Xiaoxing Huang, Hailong Zhang, Jun Yang, Jingfan Wu, John McMahon,Yufan Lin, Zhonglian Cao, Michael Gruentha, and Yunfei Huang. Pharmacological inhibition of the mammalian target of rapamycin pathway suppresses acquired epilepsy. Neurobiology of Disease, 2010, 40(1):193-1991
5. Zhonglian Cao, Dan Li, Li Liu, Ping Yang.  Effect of 5 Novel 5-Substituted Tetrandrine Derivatives on P-Glycoprotein-Mediated Inhibition and Transport in Caco-2 Cell.  Submitted.
6. Zhonglian Cao, Xiaoxia Li, Xueling Liao, Ping Yang. To screen P-glycoprotein inhibitors in Caco-2 cell-based permeability studies coupled with the high performance liquid chromatography.  Submitted.